The global platelet-rich plasma market size was estimated at US$466.1 million in 2020 and is expected to expand at a CAGR of 12.0% from 2021 to 2027. Platelet-rich plasma (PRP) is a major source We have self-made products in the field of regenerative medicine and, along with scaffolds and stem cells, are a true pioneer in the healing process. As the incidence of sports injuries and orthopedic diseases increases, the demand for PRP treatment is increasing. As the research base expands, the demand for platelet-rich plasma preparations is expected to increase.
A full report of Platelet Rich Plasma Market available at https://www.orionmarketreports.com/platelet-rich-plasma-market/27794/
Platelet Rich Plasma Market Segmentations
By Product
• Pure PRP
• Leukocyte Rich PRP
• Leukocyte Rich Fibrin
By Origin
• Autologous PRP
• Allogeneic PRP
• Homologous PRP
By Application
• Orthopedic Surgery
• Cosmetic Surgery
• General Surgery
• Neurosurgery
• Others
Major Players
• Johnson & Johnson (DePuy Synthes)
• Zimmer Biomet
• Stryker
• EmCyte Corporation
• Terumo BCT, Inc.;
• Arthrex, Inc.
• Dr. PRP America
• Juventix
• APEX Biologix
• Celling BioSciences
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
